Polyp of middle ear

H8_POLYPMIDD

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H74.4 Cause of death: ICD-10 — H74.4 2 out of 7 registries used, show all original rules.	58
4. Check minimum number of events None	58
5. Include endpoints None	58
6. Filter based on genotype QC (FinnGen only)	58

Control definitions (FinnGen only)

Control exclude: H8_MIDDLEMASTOID

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H74
Name in latin: Polypus auris mediae

NAME	H8_POLYPMIDD
CONTROL_EXCLUDE	H8_MIDDLEMASTOID
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H744
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H744
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Polyp of middle ear based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	794	336	456
Only index persons	694	295	399
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.02
Median age at first event (years)
Whole population	11.75	10.66	12.26
Only index persons	13.86	11.53	15.58

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	58	30	28
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	48.50	44.56	52.71

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019225) pH of Specimen

3.96

3.21

3.0

7.0

—

(3000494) Fungus identified in Specimen by Culture

3.23

3.16

1.6

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3.34

2.95

2.7

7.1

0.2

1.8

mmol/l

—

(3022313) Gas panel - Capillary blood

3.69

2.93

3.0

8.2

—

(3009343) pH of Capillary blood

3.26

2.85

2.7

7.0

—

7.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

5.01

2.33

1.3

2.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2.83

2.28

5.9

4.4

37.1

33.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

3.27

2.02

3.3

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.72

1.99

3.8

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

4.86

1.98

1.2

2.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3.81

1.89

4.0

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3.03

1.87

2.5

2.2

96.8

127.1

ng/l

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

4.45

1.86

1.0

1.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

2.69

1.56

3.1

1.8

64.4

66.6

g/l

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.56

1.28

1.2

1.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

2.21

1.25

27.4

16.7

1.5

1.2

inr

—

(3044640) Blood type and Crossmatch panel - Blood

130

1.82

1.25

3.3

2.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1.90

1.23

3.5

2.8

—

(3013512) EKG study

114

1.84

1.21

5.5

3.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

0.00

1.20

0.0

3.2

—

(40761536) Microorganisms panel - Urine sediment

0.00

1.18

0.0

4.4

—

(3025941) Bacteria identified in Stool by Culture

0.00

1.00

0.0

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

0.00

0.98

0.0

2.3

—

(1761868) Lipid panel - Serum or Plasma

159

0.55

0.89

2.3

2.7

—

(21494755) Public health laboratory ask at order entry panel

1.86

0.87

1.6

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.82

0.86

3.6

2.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

0.00

0.79

0.0

1.1

—

(3002256) Pathology report gross observation

1.80

0.73

1.1

1.2

—

(3003694) ABO and Rh group [Type] in Blood

123

0.59

0.63

1.3

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

0.00

0.61

0.0

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

0.00

0.61

0.0

2.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

402

1.53

0.61

4.7

3.8

1.3

1.2

mmol/l

0.16

362

(3041096) Erythrocytes [Presence] in Urine by Automated

131

0.63

0.61

1.9

3.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

413

1.55

0.61

13.5

12.2

82.0

83.7

ml/min/173m2

0.18

328

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.85

0.61

3.3

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.65

0.60

1.5

1.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

279

1.42

0.59

7.7

9.3

4.1

e9/l

0.01

246

(40761511) CBC panel - Blood by Automated count

506

0.62

0.58

14.9

12.2

—

(3026782) Osmolality of Urine

0.57

0.58

2.2

3.0

457.5

547.0

mosm/kgh2o

—

(3042936) Bacteria identified in Isolate by Culture

1.59

0.58

2.0

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.56

0.57

3.1

2.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.64

0.56

3.5

1.8

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

417

1.50

0.53

5.2

4.2

1.5

mmol/l

0.39

376

(3020682) Albumin/Creatinine [Ratio] in Urine

130

1.44

0.52

4.5

3.3

54.9

6.9

mg/mmol

—

(3023368) Bacteria identified in Blood by Culture

112

1.46

0.51

4.1

4.2

—

(3012516) Albumin [Mass/volume] in Urine

122

1.43

0.49

3.9

2.8

138.8

574.9

mg/l

—

(3000850) Epithelial cells [#/volume] in Urine

101

0.65

0.44

2.1

2.4

7.0

5.9

e6/l

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.56

0.42

1.0

1.3

—

(4010399)

1.56

0.42

1.4

1.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1.56

0.42

2.4

1.6

1.1

g/l

—

(42870588) Differential panel, method unspecified - Blood

163

1.35

0.42

4.0

6.2

—

(40768804) Tissue Pathology biopsy report

163

1.35

0.42

2.0

1.8

—

(3045414) Leukocytes [Presence] in Urine

0.00

0.42

0.0

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

0.00

0.42

0.0

1.4

—

320.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.00

0.42

0.0

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.42

0.0

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

0.42

0.0

6.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

310

1.33

0.41

2.9

4.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.00

0.40

0.0

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

0.00

0.40

0.0

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.00

0.40

0.0

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.00

0.40

0.0

1.2

—

(3026008) Bacteria identified in Urine by Culture

124

0.68

0.40

1.2

3.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

186

0.74

0.39

2.4

4.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.45

0.37

1.5

1.8

—

(36660697) Celiac disease serology panel - Serum

1.34

0.34

1.3

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

285

1.27

0.34

3.1

4.3

—

53.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

419

1.33

0.32

5.0

4.3

4.7

4.6

mmol/l

0.34

382

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

431

1.33

0.30

5.5

4.8

2.7

mmol/l

0.23

393

(3018677) aPTT in Platelet poor plasma by Coagulation assay

0.68

0.28

2.4

2.5

26.6

28.7

—

(3035350) Ketones [Presence] in Urine by Test strip

230

0.80

0.28

2.5

4.0

—

0.0

—

(36304419) Bacteria [Presence] in Urine

126

0.75

0.28

2.8

3.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

445

0.80

0.25

15.2

15.7

35.8

39.6

0.92

335

(3018095) Leukocytes [#/volume] in Urine

166

0.79

0.25

3.6

3.7

51.0

49.2

e6/l

—

120

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

145

0.78

0.24

2.5

3.4

30.6

29.9

u/l

0.05

137

(3011397) Hemoglobin [Presence] in Urine by Test strip

107

1.28

0.24

2.5

3.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

107

1.28

0.24

1.7

1.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1.34

0.24

2.2

2.1

8.6

9.5

g/l

—

(3021601) Nitrite [Presence] in Urine by Test strip

227

0.82

0.24

4.5

5.6

—

0.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.29

0.23

1.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1.21

0.22

4.0

4.4

19.1

11.9

ug/l

—

(3002582) Erythrocytes [#/volume] in Urine

143

0.80

0.22

2.7

3.1

25.9

24.6

e6/l

—

113

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

122

0.78

0.21

1.2

1.4

—

0.7

—

(3018418) pH of Serum or Plasma

122

0.78

0.21

4.3

3.4

—

7.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.21

0.0

2.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.21

0.0

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.21

0.0

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.21

0.0

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

0.00

0.21

0.0

1.8

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.31

0.21

1.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(40768793) Breast Pathology biopsy report

0.00

0.21

0.0

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.00

0.20

0.0

1.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.20

0.0

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

0.00

0.20

0.0

1.4

—

129.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.6

—

41.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.23

0.19

1.0

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.21

0.19

3.3

9.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.18

0.17

1.1

1.4

—

(3015736) pH of Urine

181

0.84

0.17

2.4

3.5

—

(3009261) Glucose [Presence] in Urine by Test strip

231

0.86

0.16

2.6

4.1

—

0.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

400

1.18

0.16

6.9

5.5

43.6

40.4

mmol/mol

0.59

373

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

484

1.24

0.15

13.8

13.5

19.9

23.9

mg/l

0.40

374

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

330

1.15

0.15

2.8

3.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

166

1.12

0.09

5.2

4.0

21.5

40.9

ng/l

0.52

119

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

117

1.14

0.09

5.2

4.1

14.1

22.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.04

0.09

1.5

1.3

—

(3012544) pH of Venous blood

1.04

0.09

2.8

5.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1.05

0.08

1.1

1.2

—

39.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

439

1.11

0.06

5.2

4.3

2.2

1.9

mu/l

0.83

395

(3024561) Albumin [Mass/volume] in Serum or Plasma

190

0.92

0.04

2.3

5.8

31.5

35.3

g/l

1.10

181

(3044889) 12 lead EKG panel

300

0.93

0.04

2.8

3.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1.09

0.02

1.4

1.8

453.4

481.5

pmol/l

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

427

0.94

0.01

4.9

4.5

6.1

5.9

mmol/l

0.24

387

(3019150) Specific gravity of Urine by Refractometry

114

1.07

0.01

2.3

3.4

1.0

kg/l

—

(40758558) Short blood count panel - Blood

124

1.06

0.01

4.1

5.4

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

156

0.95

0.00

2.5

3.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

111

0.99

0.00

2.5

4.9

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

239

1.01

0.00

5.5

6.2

9.3

15.4

umol/l

2.03

224

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

344

0.97

0.00

4.8

3.8

14.5

14.9

pmol/l

0.28

314

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

156

1.04

0.00

2.5

1.8

89.3

94.2

pmol/l

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

198

1.02

0.00

5.3

4.7

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

152

0.98

0.00

1.6

3.1

2.3

2.4

mmol/l

—

133

(3024928) Oxygen saturation in Venous blood

0.00

0.0

8.7

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.0

1.8

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.5

—

254.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.0

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

0.00

0.0

1.3

—

0.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.0

1.3

—

(4027681)

0.00

0.0

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

0.0

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.8

—

(3045424) Erythrocytes [Presence] in Urine

0.00

0.0

1.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

0.0

1.3

—

17.1

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.0

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.00

0.0

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.0

1.3

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

0.00

0.0

1.7

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

0.0

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

0.0

1.1

—

(3000991) Gas panel - Venous blood

0.98

0.00

7.0

9.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.0

1.4

—

(3010421) pH of Blood

0.00

0.0

2.4

—

7.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.0

1.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

0.00

0.0

1.2

—

37.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

4.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.0

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.0

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

0.00

0.0

5.0

—

(3045788) Cell count panel - Pleural fluid

0.00

0.0

1.2

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.0

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

0.0

2.4

—

8.9

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

0.0

1.2

—

188.9

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.0

2.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.0

1.3

—

(40768806) Pleura Pathology biopsy report

0.00

0.0

1.0

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

3.8

—

290.9

—

(3014051) Protein [Presence] in Urine by Test strip

0.00

0.0

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.0

1.0

—

(3023410) Appearance of Cerebral spinal fluid

0.00

0.0

2.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

0.0

1.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.0

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

0.0

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.0

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.0

1.7

—

62.7

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

0.00

0.0

1.2

—

6.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

0.00

0.0

1.3

—

9.8

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.0

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.4

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

0.0

1.6

—

90.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.0

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

0.00

0.0

1.3

—

0.4

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

0.0

6.6

—

3.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.0

1.6

—

88.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.8

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

0.0

5.9

—

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(40768441) Liver Pathology biopsy report

0.00

0.0

1.6

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

0.0

2.4

—

5.2

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.0

1.0

—

178.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.0

1.7

—

5.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

0.00

0.0

4.1

—

0.9

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_POLYPMIDD and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have H8_POLYPMIDD.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: H8_POLYPMIDD – Polyp of middle ear

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Polyp of middle ear

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints